A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol

Journal of Pharmacological Sciences

Volumn 108, Issue 1, 2008, Pages 124-130

  Gojkovic Bukarica, Ljiljana ^a   Novakovic, Aleksandra ^a   Kanjuh, Vladimir ^b   Bumbasirevic, Marko ^c   Lesic, Aleksandar ^c   Heinle, Helmut ^d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b SERBIAN ACADEMY OF SCIENCES AND ARTS   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ion channel; K+ channel; Rat mesenteric artery; Resveratrol; Vasorelaxation

Indexed keywords

4 AMINOPYRIDINE; BARIUM CHLORIDE; CHARYBDOTOXIN; GLIBENCLAMIDE; MARGATOXIN; NIFEDIPINE; PHENYLEPHRINE; POTASSIUM CHANNEL; POTASSIUM ION; RESVERATROL; TETRYLAMMONIUM; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY MUSCLE; ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; NONHUMAN; RAT; SMOOTH MUSCLE RELAXATION;

EID: 52949145570     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08128FP     Document Type: Article

References (42)

1. Wu JM, Wang ZR, Hsieh, TC, Bruder JL, Zou JG, Huang YZ. Mechanism of cardioprotection by resveratrol, a phenolic anti-oxidant present in red wine (Review). Int J Mol Med. 2001;8:3-17.
2. Opie HL, Lecour S. The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J. 2007;28:1683-1693.
3. Das DK, Maulik N. Resveratrol in cadrioprotection: A therapeutic promise of alternative medicine. Mol Interv. 2006;6: 36-47.
4. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol. 1993;265:H774-H778.
5. Naderali EK, Doyle JP, Williams G. Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin Sci. 2000;98:537-543.
6. Naderali EK, Smith LH, Doyle JP, Williams G. The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats. Clin Sci. 2001;100:55-60.
7. Novakovic A, Gojković-Bukarica L, Peric M, Nezic D, Djukanovic B, Marković-Lipkovski J, et al. The mecanism of edothelium-idependent rlaxation iduced by the wine polyphenol resveratrol in human internal mammary artery. J Pharmacol Sci. 2006;101:85-90.
8. Ray PS, Maulik G, Cordis GA, Bertelli AA, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med. 1999;27:160-169.
9. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493-506.
10. Calderone V, Martelli A, Testai L, Martinotti E, Breschi MC. Functional contribution of the endothelial component to the vasorelaxing effects of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels. Naunyn Schmiedebergs Arch Pharmacol. 2007;375:73-80.
11. Andriambeloson E, Stoclet JC, Andriantsitohaina R. Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol. 1999;33:248-254.
12. Jager U, Nguyen-Duong H. Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneimittelforschung. 1999;49:207-211.
13. El-Mowafy AM, Alkhalaf M. Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis. 2003;24: 869-873.
14. El-Mowafy. Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: a novel signaling mechanism in support of coronary protection. Biochem Biophys Res Commun. 2002;291:1218-1224.
15. Dell'Agli M, Galli GV, Vrhovsek U, Mattivi F, Bosisio E. In vitro inhibition of human cGMP-specific phosphodiesterase-5 by polyphenols from red grapes. J Agric Food Chem. 2005;23: 1960-1965.
16. Novakovic A, Bukarica Gojkovic Lj, Kanjuh V, Heinle H. Potassium Channels Mediated Vasorelaxation of Rat Aorta Induced by Resveratrol. Basic Clin Pharmacol Toxicol. 2006; 99:360-364.
17. Orsini F, Verotta L, Lecchi M, Restano R, Curia G, Redaelli E, et al. Resveratrol derivates and their role as potassium channels modulators. J Nat Prod. 2004;67:421-442.
18. Nagaoka T, Hein TW, Yoshida A, Kuo L. Resveratrol, a component of red wine, elicts dilatation of isolated porcine retinal arterioles: role of nitric oxide and potassium channels. Invest Opthalmol Vis Sci. 2007;48:4232-4239.
19. Orallo F. Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normoten-sive rats. Br J Pharmacol. 1997;121:1627-1636.
20. Gojkovic-Bukarica Lj, Kazic T, Sajic Z, Djukanovic B, Panic G, Peric M. The effects of levcromakalim and pinacidil on the human internal mammary artery. Fundam Clin Pharmacol. 1997;11:550-560.
21. Schoeffter P, Dion R, Godfraind T. Modulatory role of the vascular endothelium in the contractility of human isolated internal mammary artery. Br J Pharmacol. 1988;95:531-543.
22. Naderali KE, Smith LH, Doyle JP, Williams G. The mechanism of resveratrol-induced vasorelaxation differs in the mesenteric resistance arteries of lean and obese rats. Clin Sci. 2001;100:55-60.
23. Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol. 1995;26:90-95.
24. Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol. 1996;27:363-366.
25. Rakici O, Kiziltepe U, Coskun B, Aslamaci S, Akar F. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int J Cardiol. 2005;105:209-215.
26. Li FH, Tian FZ, Qiu XQ, Wu XJ, Zhang P, Jia JZ. A study of mechanisms involved in vasodilatation induced by resveratrol in isolated porcine coronary artery. Physiol Res. 2006;55:365-372.
27. Sturgess NC, Ashford ML, Cook DL, Hales CN. The sulfonylurea receptor may be an ATP-sensitive potassium channel. Lancet. 1985;2:474-475.
28. + channel in insulin-secreting cells. J Biol Chem. 1987;262:15840-15844.
29. Cook NS, Quast U. Potassium channel pharmacology. In: Cook, NS, editor. Potassium channels: structure, classification, function, and therapeutic potential, New York: John Wiley and Sons; 1990. p. 181-258.
30. Granados-Soto V, Arguelles CF, Ortiz MI. The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels. Neuropharmacology. 2002;43:917-923.
31. Wang GY, Song CM, Zhang LN, Li Q, Yue H, Feng JK, et al. Roles of potassium channel in effect of resveratrol on isolated myocardial contractility and heart rate research in guinea pig. Zhongguo Zhong Yao Za Zhi. 2007;32:1317-1319.
32. Wallner M, Meera P, Toro L. Calcium-activated potassium channels in muscle and brain. In: Kurachi Y, Jan LY, Lazdunski M, editors. Current Topics in Membrane, Volume 46: Potassium ion channels, Molecular structure, function, and diseases, San Diego: Academic Press; 1999. p. 117-135.
33. + channels: physiological role and pharmacology. Curr Med Chem. 2003;10:649-661.
34. + channel-blocking peptide. Neuron. 1995;15:5-10.
35. Alexander SP, Mathie A, Peters JA. Guide to receptors and channels, 2nd edition. Br J Pharmacol. 2006;147 Suppl 3:S1-S168.
36. + channel genes in mesenteric artery smooth muscle cells. Am J Gastrointest Liver Physiol. 1999;277:G1055-G1063.
37. Beech DJ, Bolton TB. Properties of the cromakalim induced potassium conductance in smooth muscle cells isolated from the rabbit portal vein. Br J Pharmacol. 1989;98:851-864.
38. Garcia-Calvo M, Leonard RJ, Novick J, Stevens SP, Schmalhofer W, Kaczorowski GJ, et al. Purification, characterization, and biosynthesis of margatoxin, a component of centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J Biol Chem. 1993;268: 18866-18874.
39. V1.1 at enteric nervous system and enhancing acetylcholine release. J Pharmacol Exp Ther. 1999;289:1517-1522.
40. V2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes. J Clin Invest. 1998;101:2319-2330.
41. Zheng L, Li-Ping Z, Hui-Jie M, Chuan W, Ming L, Qing-Shan W. Resveratrol reduces intracellular free calcium concentration in rat ventricular myocytes. Acta Physiologica Sinica. 2005;57: 599-604.
42. Campos-Toimil E, Elies J, Alvarez E, Verde I, Orallo F. Effects of trans- and cis-resveratrol on Ca(2+) handling in A7r5 vascular myocytes. Eur J Pharmacol. 2007;577:91-99.